Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants
V. Spoulou et al., Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants, J INFEC DIS, 182(3), 2000, pp. 965-969
The kinetics of the immune response to the 23-valent pneumococcal polysacch
aride vaccine (PPV) were studied in 38 children who received bone marrow tr
ansplants (BMTs), Antipneumococcal antibody concentrations increased 1 and
3 months after vaccination for all 5 serotypes tested, but, in 21 children,
the vaccine was not adequately immunogenic, Children vaccinated <18 months
after receiving a BMT had a 4.2-fold increased odds of poor response (P =.
06). Antibody concentrations returned close to baseline levels 9 months aft
er vaccination. Avidity declined significantly as early as 1 month after va
ccination and remained low thereafter. Antibody concentration responses to
PPV were superior among 9 healthy control children (P =.001); 37 of 38 chil
dren with a BMT elicited adequate, persistent immune responses to Haemophil
us influenzae conjugate vaccine. Immune responses to PPV in children with a
BMT are suboptimal, short lived, and associated with declining avidity. Th
e different kinetics of antibody concentration and avidity indicate that bo
th markers should be used for evaluating pneumococcal vaccines in this high
-risk population.